Pharmaceutical cream with reduced imiquimod impurities at four months using refined oleic acid

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7902213
APP PUB NO 20100120835A1
SERIAL NO

12697972

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Pharmaceutical formulations and methods including an immune response modifier (IRM) compound and an oleic acid component are provided where stability is improved by using oleic acid have low polar impurities such as peroxides.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
MEDICIS PHARMACEUTICAL CORPORATIONSCOTTSDALE, AZ108

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Nelson, Robert J Cottage Grove, US 92 2680
Statham, Alexis S Woodbury, US 36 628

Cited Art Landscape

Patent Info (Count) # Cites Year
 
Other [Check patent profile for assignment information] (2)
2003/0026,794 Selective enzyme treatment of skin conditions 40 2001
2003/0059,471 Oral delivery formulation 134 2001
 
Minnesota Mining and Manufacturing Company (2)
4411893 Topical medicament preparations 76 1982
5346905 1-substituted 1H-imidazo-[4,5-C]quinolin-4-amines 248 1992
 
Kythera Biopharmaceuticals, Inc. (1)
2005/0201,959 Methods and compositions for altering skin coloration 31 2004
 
ALZA CORPORATION (2)
4746515 Skin permeation enhancer compositions using glycerol monolaurate 115 1987
6210712 Dosage form having first and second coats 67 1998
 
THERATECH, INC. (1)
4863970 Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols 214 1988
 
PERICOR SCIENCE, INC. (1)
6267957 Attaching agents to tissue with transglutaminase and a transglutaminase substrate 91 1999
 
GRACEWAY PHARMACEUTICALS, LLC (2)
4689338 1H-Imidazo[4,5-c]quinolin-4-amines and antiviral use 349 1985
5238944 Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine 255 1992
 
LUITPOLD PHARMACEUTICALS, INC. (1)
5919815 Taxane compounds and compositions 110 1996
 
MEPHA AG (1)
2006/0039,931 Stable cream preparations of phenyl-pyridone compounds for topical application 34 2003
 
TAKEDA PHARMACEUTICAL COMPANY LIMITED (1)
6194425 Imidazonaphthyridines 197 1998
 
Corium International, Inc. (2)
6803420 Two-phase, water-absorbent bioadhesive composition 97 2002
2003/0170,308 Hydrogel compositions 108 2002
 
Fujimori Kogyo Co., Ltd. (1)
4686125 Film laminate for sterile flexible containers 105 1984
 
NOVEN PHARMACEUTICALS, INC. (3)
5300291 Method and device for the release of drugs to the skin 99 1991
6562363 Bioadhesive compositions and methods for topical administration of active agents 188 1998
6638528 Compositions and methods to effect the release profile in the transdermal administration of active agents 135 2002
 
COLEY PHARMACEUTICAL GROUP, INC. (10)
5268376 1-substituted 1H-imidazo[4,5-c]quinolin-4-amines 251 1991
5266575 2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines 246 1991
5352784 Fused cycloalkylimidazopyridines 245 1993
5446153 Intermediates for imidazo[4,5-c]pyridin-4-amines 209 1994
5482936 Imidazo[4,5-C]quinoline amines 223 1995
6376669 Dye labeled imidazoquinoline compounds 179 2000
6660735 Urea substituted imidazoquinoline ethers 147 2002
6677347 Sulfonamido ether substituted imidazoquinolines 142 2002
6677348 Aryl ether substituted imidazoquinolines 142 2002
2004/0176,367 1-Amino 1H-imidazoquinolines 88 2004
 
ABB TECHNOLOGY AG (1)
2004/0089,855 High oleic acid oil compositions and methods of making and electrical insulation fluids and devices comprising the same 33 2003
 
Galenix Innovations (2)
2003/0096,012 Film-forming powder, compositions containing it, methods for their preparation and their uses 73 2002
2003/0124,191 Use of an immediate-release powder in pharmaceutical and nutraceutical compositions 66 2002
 
HENKEL IP & HOLDING GMBH (1)
2002/0128,345 Hot melt adhesives for dermal application 39 2000
 
INTERCONNECTRON GMBH (1)
6425776 Circular plug and socket connector for producing electrical line connections 33 2000
 
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (1)
2005/0175,630 Immunogenic compositions and methods of use thereof 50 2004
 
ASTRA AKTIEBOLAG (1)
6103697 Peptides with immunomodulatory effects 35 1997
 
3M INNOVATIVE PROPERTIES COMPANY (25)
6039969 Immune response modifier compounds for treatment of TH2 mediated and related diseases 239 1997
6110929 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof 203 1999
6245776 Formulations and methods for treatment of mucosal associated conditions with an immune response modifier 235 2000
6200592 Immine response modifier compounds for treatment of TH2 mediated and related diseases 108 2000
6331539 Sulfonamide and sulfamide substituted imidazoquinolines 195 2000
6451810 Amide substituted imidazoquinolines 173 2000
6656938 Urea substituted imidazoquinoline ethers 148 2001
6660747 Amido ether substituted imidazoquinolines 143 2001
6664260 Heterocyclic ether substituted imidazoquinolines 137 2001
6664264 Thioether substituted imidazoquinolines 148 2001
6670372 Aryl ether substituted imidazoquinolines 142 2001
6683088 Sulfonamido ether substituted imidazoquinolines 142 2001
6756382 Amide substituted imidazoquinolines 115 2001
6525064 Sulfonamido substituted imidazopyridines 165 2002
6545016 Amide substituted imidazopyridines 161 2002
6545017 Urea substituted imidazopyridines 162 2002
6664265 Amido ether substituted imidazoquinolines 148 2002
6667312 Thioether substituted imidazoquinolines 147 2002
2003/0199,538 Pharmaceutical formulation comprising an immune response modifier 110 2002
6677349 Sulfonamide and sulfamide substituted imidazoquinolines 144 2003
6797718 Ether substituted imidazopyridines 112 2003
2004/0091,491 Immunostimulatory compositions and methods of stimulating an immune response 100 2003
6818650 1H-imidazo dimers 112 2003
2004/0132,766 1H-imidazo dimers 56 2003
2004/0147,543 Aryl substituted imidazoquinolines 94 2003
 
CRESCITA THERAPEUTICS INC. (1)
2005/0276,842 Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same 75 2005
 
Nippon Oil & Fats Co. Ltd. (1)
4601856 Method of purifying oleic acid 35 1985
 
MEDICIS PHARMACEUTICAL CORPORATION (7)
5389640 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines 277 1992
5736553 Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo?4,5-C!quinolin-4-amine 68 1995
5939090 Gel formulations for topical drug delivery 198 1996
6541485 Urea substituted imidazoquinolines 156 2000
6573273 Urea substituted imidazoquinolines 150 2001
2004/0192,585 Treatment for basal cell carcinoma 84 2004
2007/0167,479 Immune response modifier formulations and methods 58 2005
 
AGIS INDUSTRIES (1983) LTD. (1)
2006/0034,779 Foamable compositions containing vitamin D3 analogues, processes for preparing same and methods of treatment utilizng same 35 2005
 
The Procter & Gamble Company (1)
5008110 Storage-stable transdermal patch 117 1988
 
WARNER-LAMBERT COMPANY LLC (1)
4908389 Penetration enhancement system 58 1986
 
SHISEIDO COMPANY, LTD. (1)
5472982 Emulsified external treatment composition containing diclofenac sodium 31 1993
 
RIKER LABORATORIES, INC. (4)
4751087 Transdermal nitroglycerin delivery system 100 1985
4698348 1H-imidazo[4,5-c]quinolines and their use as bronchodilating agents 280 1985
4929624 Olefinic 1H-imidazo(4,5-c)quinolin-4-amines 287 1989
5756747 1H-imidazo?4,5-c!quinolin-4-amines 208 1995
 
COGNIS CORPORATION (1)
6498261 Process for improving color and color stability of oleic acid 31 1995
 
DERMATRENDS, INC. (1)
2003/0072,814 Topical pharmaceutical composition for the treatment of warts 94 2002
 
LTS LOHMANN THERAPIE-SYSTEME AG (1)
7056528 Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin 34 2000
 
Hisamitsu Pharmaceuticals (1)
7504114 Preparations for percutaneous absorption 36 2000
 
Purcell Jojoba International, LLC (1)
6559182 Method for treatment of enveloped viruses using jojoba oil esters 33 2001
 
VIRUN, INC. (1)
2005/0281,772 Compositions for mucosal delivery of agents 67 2005
 
PERRIGO ISRAEL PHARMACEUTICALS LTD. (1)
2006/0024,243 Foamable compositions containing nitro-imidazoles, processes for preparing same and methods of treatment utilizing same 31 2005
 
RANBAXY LABORATORIES LIMITED (1)
2005/0037,030 Stable topical formulation of clarithromycin 30 2004
 
TAKEDA CHEMICAL INDUSTRIES, LTD. (1)
4695465 Soft patch 127 1985
 
A.V. Topchiev Institute of Petrochemical Syntheses, Russian Academy of Sciences (1)
2004/0242,770 Covalent and non-covalent crosslinking of hydrophilic polymers and adhesive compositions prepared therewith 72 2004
 
PHARMACIA & UPJOHN COMPANY LLC (1)
2003/0211,163 Combination antiviral therapy 39 2003
 
MITSUI CHEMICALS, INC. (1)
5532030 Polyolefin multilayer laminate, vessel and packaging material 70 1995
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
3M INNOVATIVE PROPERTIES COMPANY (36)
8378102 ] ring compounds and methods 0 2006
* 2008/0318,998 Alkyloxy Substituted Thiazoloquinolines and Thiazolonaphthyridines 52 2006
8658666 Substituted imidazoquinolines and imidazonaphthyridines 3 2006
* 2009/0099,161 Substituted Imidazoquinolines and Imidazonaphthyridines 48 2006
8846710 Method of preferentially inducing the biosynthesis of interferon 1 2006
8343993 Hydroxyalkyl substituted imidazonaphthyridines 1 2006
8178677 Hydroxyalkyl substituted imidazoquinolines 3 2006
8158794 Hydroxyalkyl substituted imidazoquinoline compounds and methods 3 2006
* 2009/0069,314 Hydroxyalkyl Substituted Imidazoquinoline Compounds and Methods 51 2006
* 2009/0029,988 Hydroxyalkyl Substituted Imidazoquinolines 51 2006
* 2009/0030,031 Method of Preferentially Inducing the Biosynthesis of Interferon 52 2006
8476292 Amide and carbamate derivatives of N-{2-[4-amino-2-(ethoxymethyl)-1H-imidazo[4,5-c] quinolin-1-Yl]-1,1-dimethylethyl}methanesulfonamide and methods 0 2006
8188111 -imidazo[4,5-c]quinolin-1-yl)butyI]methanesulfonamides and methods 0 2006
8088790 -imidazoquinolines and methods 2 2006
8329721 -imidazonaphthyridines and methods 0 2007
8178539 ]phenalenes and methods 0 2007
* 2010/0173,906 Substituted 3,4,6,7-Tetrahydro-5H-1,2a,4a,8-Tetraazacyclopenta[cd]Phenalenes and Methods 28 2007
8541438 Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines 2 2010
* 2011/0092,477 SUBSTITUTED IMIDAZOQUINOLINES, IMIDAZOPYRIDINES, AND IMIDAZONAPHTHYRIDINES 0 2010
8263594 Aryloxy and arylalkyleneoxy substituted imidazoquinolines 1 2011
* 2011/0144,099 ARYLOXY AND ARYLALKYLENEOXY SUBSTITUTED IMIDAZOQUINOLINES 1 2011
8207162 ] ring compounds 1 2011
8350034 Substituted chiral fused [1,2]imidazo[4,5-C] ring compounds 0 2011
9242980 Lipidated immune response modifier compound compositions, formulations, and methods 0 2011
8377957 Hydroxy and alkoxy substituted 1H-imidazoquinolines and methods 0 2011
9145410 Pyrazolopyridines and analogs thereof 0 2012
8546383 Chiral fused [1,2]imidazo[4,5-c] ring compounds 0 2012
9475804 Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom 0 2012
9107958 Hydrazino 1H-imidazoquinolin-4-amines and conjugates made therefrom 1 2012
9006264 Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines 1 2013
9328110 Substituted imidazo ring systems and methods 0 2014
9365567 Alkoxy substituted imidazoquinolines 0 2014
9550773 Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines 0 2015
9546184 Alkyloxy substituted thiazoloquinolines and thiazolonaphthyridines 0 2015
9585968 Hydrazino 1H-imidazoquinolin-4-amines and conjugates made therefrom 0 2015
9765071 Substituted imidazo ring systems and methods 0 2016
 
MEDICIS PHARMACEUTICAL CORPORATION (6)
* 2010/0160,368 Methods of Treating Dermatological Disorders and Inducing Interferon Biosynthesis With Shorter Durations of Imiquimod Therapy 5 2009
* 2011/0207,766 LOWER DOSAGE STRENGTH IMIQUIMOD FORMULATIONS AND SHORT DOSING REGIMENS FOR TREATING GENITAL AND PERIANAL WARTS 2 2010
8598196 Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy 0 2012
8642616 Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts 0 2012
9271973 Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy 0 2013
9078889 Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts 1 2013
 
PFIZER INC. (1)
* 2009/0298,821 HYDROXY AND ALKOXY SUBSTITUTED IH-IMIDAZONAPHTHYRIDINES AND METHODS 30 2007
* Cited By Examiner

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 8, 2018
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 8, 2022
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00